Робалзотан (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Робалзотан" in Russian language version.

refsWebsite

Global rank Russian rank

4^th place

6^th place

low place

2^nd place

3^rd place

doi.org

Jerning E., Svantesson G.T., Mohell N. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist. (англ.) // Eur J Pharmacol.^[англ.] : journal. — 1998. — Vol. 360, no. 2—3. — P. 219—225. — doi:10.1016/S0014-2999(98)00667-0. — PMID 9851589.
Arborelius L., Wallsten C., Ahlenius S., Svensson TH. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing. (англ.) // Eur J Pharmacol.^[англ.] : journal. — 1999. — Vol. 382, no. 2. — P. 133—138. — doi:10.1016/S0014-2999(99)00592-0. — PMID 10528148.
Drossman D.A., Danilewitz M., Naesdal J., Hwang C., Adler J., Silberg D.G. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome (англ.) // The American Journal of Gastroenterology^[англ.] : journal. — 2008. — October (vol. 103, no. 10). — P. 2562—2569. — doi:10.1111/j.1572-0241.2008.02115.x. — PMID 18775020.

Jerning E., Svantesson G.T., Mohell N. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist. (англ.) // Eur J Pharmacol.^[англ.] : journal. — 1998. — Vol. 360, no. 2—3. — P. 219—225. — doi:10.1016/S0014-2999(98)00667-0. — PMID 9851589.
Arborelius L., Wallsten C., Ahlenius S., Svensson TH. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing. (англ.) // Eur J Pharmacol.^[англ.] : journal. — 1999. — Vol. 382, no. 2. — P. 133—138. — doi:10.1016/S0014-2999(99)00592-0. — PMID 10528148.
Mucke HA. Robalzotan AstraZeneca. (неопр.) // Curr Opin Investig Drugs.. — 2000. — Т. 1, № 2. — С. 236—240. — PMID 11249580.
Drossman D.A., Danilewitz M., Naesdal J., Hwang C., Adler J., Silberg D.G. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome (англ.) // The American Journal of Gastroenterology^[англ.] : journal. — 2008. — October (vol. 103, no. 10). — P. 2562—2569. — doi:10.1111/j.1572-0241.2008.02115.x. — PMID 18775020.

Jerning E., Svantesson G.T., Mohell N. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist. (англ.) // Eur J Pharmacol.^[англ.] : journal. — 1998. — Vol. 360, no. 2—3. — P. 219—225. — doi:10.1016/S0014-2999(98)00667-0. — PMID 9851589.
Arborelius L., Wallsten C., Ahlenius S., Svensson TH. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing. (англ.) // Eur J Pharmacol.^[англ.] : journal. — 1999. — Vol. 382, no. 2. — P. 133—138. — doi:10.1016/S0014-2999(99)00592-0. — PMID 10528148.
Drossman D.A., Danilewitz M., Naesdal J., Hwang C., Adler J., Silberg D.G. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome (англ.) // The American Journal of Gastroenterology^[англ.] : journal. — 2008. — October (vol. 103, no. 10). — P. 2562—2569. — doi:10.1111/j.1572-0241.2008.02115.x. — PMID 18775020.